Talia Faison

Center for Drug Evaluation and Research,

Office of Product Quality,

Office of Biotechnology Products,

Division of Biotechnology Review and Research II,

Center for Drug Evaluation and Research, Office of Product Quality, Office of Biotechnology Products, Division of Biotechnology Review and Research II

U.S. Food and Drug Administration

Utilizamos cookies para mejorar su experiencia en nuestra página web.

Al continuar usando nuestro sitio web o al hacer clic en 'Continuar', está aceptando nuestras cookies.

Saber más